-
Homepage -
Online Submission
- Artificial Intelligence in Cancer
- Artificial Intelligence in Gastroenterology
- Artificial Intelligence in Gastrointestinal Endoscopy
- Artificial Intelligence in Medical Imaging
- World Journal of Anesthesiology
- World Journal of Biological Chemistry
- World Journal of Cardiology
- World Journal of Clinical Cases
- World Journal of Clinical Infectious Diseases
- World Journal of Clinical Oncology
- World Journal of Clinical Pediatrics
- World Journal of Clinical Urology
- World Journal of Critical Care Medicine
- World Journal of Dermatology
- World Journal of Diabetes
- World Journal of Experimental Medicine
- World Journal of Gastroenterology
- World Journal of Gastrointestinal Endoscopy
- World Journal of Gastrointestinal Oncology
- World Journal of Gastrointestinal Pathophysiology
- World Journal of Gastrointestinal Pharmacology and Therapeutics
- World Journal of Gastrointestinal Surgery
- World Journal of Hematology
- World Journal of Hepatology
- World Journal of Hypertension
- World Journal of Immunology
- World Journal of Medical Genetics
- World Journal of Meta-Analysis
- World Journal of Methodology
- World Journal of Nephrology
- World Journal of Neurology
- World Journal of Obstetrics and Gynecology
- World Journal of Ophthalmology
- World Journal of Orthopedics
- World Journal of Otorhinolaryngology
- World Journal of Pharmacology
- World Journal of Psychiatry
- World Journal of Radiology
- World Journal of Respirology
- World Journal of Rheumatology
- World Journal of Stem Cells
- World Journal of Stomatology
- World Journal of Surgical Procedures
- World Journal of Translational Medicine
- World Journal of Transplantation
- World Journal of Virology
- 世界华人消化杂志
| For: | Francini E, Mazzaroppi S, Fiaschi AI, Petrioli R, Laera L, Roviello G, Pira T, Pellicelli AM, Bianco V. Safety of Sorafenib Therapy in Elderly Adults with Advanced Hepatocellular Carcinoma. J Am Geriatr Soc 2014;62:2204-5. [DOI: 10.1111/jgs.13091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis] |
|---|
| Number | Citing Articles |
| 1 | Ziogas DC, Papadatos-pastos D, Thillai K, Korantzis I, Chowdhury R, Suddle A, O’grady J, Al-khadimi G, Allen N, Heaton N, Ross PJ, Sarker D. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem. European Journal of Gastroenterology & Hepatology 2017;29:48-55. [DOI: 10.1097/meg.0000000000000739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis] |
| 2 | Williet N, Clavel L, Bourmaud A, Verot C, Bouarioua N, Roblin X, Merle P, Phelip JM. Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma. Dig Liver Dis. 2017;49:1043-1049. [PMID: 28712860 DOI: 10.1016/j.dld.2017.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis] |
| 3 | Hajiev S, Allara E, Motedayеn Aval L, Arizumi T, Bettinger D, Pirisi M, Rimassa L, Pressiani T, Personeni N, Giordano L, Kudo M, Thimme R, Park JW, Taddei TH, Kaplan DE, Ramaswami R, Pinato DJ, Sharma R. Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study. Br J Cancer 2021;124:407-13. [PMID: 33071284 DOI: 10.1038/s41416-020-01116-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis] |